TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Nec Oncoimmunity AS
Closing information (x1000 SEK)
| Closing information | 2025/03 | 2024/03 | 2023/03 |
| Turnover |
38,558
|
44,382
|
3,208 |
| Financial expenses |
1,434
|
2,206
|
2,392 |
| Earnings before taxes |
-64,538
|
-44,330
|
-36,228 |
| Total assets |
69,438
|
86,501
|
72,712 |
| Current assets |
64,021
|
80,495
|
65,001 |
| Current liabilities |
27,381
|
41,519
|
12,329 |
| Equity capital |
42,058
|
44,981
|
60,383 |
| - share capital |
369
|
366
|
350 |
| Employees (average) | 18 |
Financial ratios
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Solvency |
60.6%
|
52.0%
|
83.0% |
| Turnover per employee | 178 | ||
| Profit as a percentage of turnover |
-167.4%
|
-99.9%
|
-1129.3% |
| Return on assets (ROA) |
-90.9%
|
-48.7%
|
-46.5% |
| Current ratio |
233.8%
|
193.9%
|
527.2% |
| Return on equity (ROE) |
-153.4%
|
-98.6%
|
-60.0% |
| Change turnover |
-4,268
|
41,207
|
832 |
| Change turnover % |
-10%
|
1298%
|
35% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2025/03 | 2024/03 | 2023/03 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.